Home/Filings/3/0001140361-21-032354
3//SEC Filing

Sherpa Ventures Fund, LP 3

Accession 0001140361-21-032354

CIK 0001628945other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 9:06 PM ET

Size

18.0 KB

Accession

0001140361-21-032354

Insider Transaction Report

Form 3
Period: 2021-09-23
Holdings
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Series B Preferred Stock

    Common Stock (3,834,088 underlying)
  • Common Stock

    129,354
  • Series A Preferred Stock

    Common Stock (5,450,898 underlying)
  • Series B Preferred Stock

    Common Stock (3,076,224 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Common Stock

    194,031
Holdings
  • Common Stock

    129,354
  • Common Stock

    194,031
  • Series B Preferred Stock

    Common Stock (3,834,088 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Series B Preferred Stock

    Common Stock (3,076,224 underlying)
  • Series A Preferred Stock

    Common Stock (5,450,898 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
Holdings
  • Series B Preferred Stock

    Common Stock (3,076,224 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Series A Preferred Stock

    Common Stock (5,450,898 underlying)
  • Common Stock

    194,031
  • Series B Preferred Stock

    Common Stock (3,834,088 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Common Stock

    129,354
Stanford Scott
Director10% Owner
Holdings
  • Common Stock

    129,354
  • Series B Preferred Stock

    Common Stock (3,076,224 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Common Stock

    194,031
  • Series A Preferred Stock

    Common Stock (5,450,898 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Series B Preferred Stock

    Common Stock (3,834,088 underlying)
Holdings
  • Series B Preferred Stock

    Common Stock (3,834,088 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
  • Common Stock

    194,031
  • Common Stock

    129,354
  • Series A Preferred Stock

    Common Stock (5,450,898 underlying)
  • Series B Preferred Stock

    Common Stock (3,076,224 underlying)
  • Series C-1 Preferred Stock

    Common Stock (1,092,329 underlying)
Footnotes (5)
  • [F1]The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II (as defined below) and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II (as defined below) and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
  • [F2]The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
  • [F3]The Series A Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F4]The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
  • [F5]The Series C-1 Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

Issuer

Cue Health Inc.

CIK 0001628945

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001580437

Filing Metadata

Form type
3
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:06 PM ET
Size
18.0 KB